Assessed the accuracy and clinical efficacy of Watch-PAT in evaluating the results of sleep surgeries such as septoplasty, tonsillectomy, or uvuloplasty in 35 obstructive sleep apnea syndrome, (OSA), patients. WatchPAT-derived respiratory disturbance index (RDI), apnea and hypopnea index (AHI), lowest oxygen saturation, and valid sleep time were measured before and after surgery. RESULTS: RDI, AHI, lowest oxygen saturation, and valid sleep time recovered to within normal range after surgery in 28 subjects. Good agreement was found between WatchPAT-derived factors and visual analogue scales for changes in subjective symptoms, (snoring, apnea, and daytime somnolence). In 7/35 subjects, who showed no improvement for their subjective symptoms after surgery, RDI and AHI were not reduced, and lowest oxygen saturation and valid sleep time were not elevated. CONCLUSION: WatchPAT is a highly sensitive portable device for estimating treatment results and symptomatic changes in OSA patients after sleep surgery for correction of airway collapse. Determined whether sleep-disordered breathing (SDB) is more prevalent among women with preeclampsia than among normotensive controls, in 20 preeclamptic patients and 20 controls matched for gestational age, using Watch-PAT100 sleep studies to diagnose and quantify SDB. RESULTS: Preeclamptic subjects had a higher mean BMI (32.6± 9.5 vs. 24.5 ± 3.5, P=0.001), higher mean respiratory disturbance indices (RDI, mean difference 4.9 events/hour of sleep), higher apnea hypopnea indices (AHI, mean difference 5.7 events/h) and higher oxygen desaturation (ODI, mean difference 4.5 events/h) indices, however these differences did not reach statistical significance. Preeclamptic subjects were more likely to have more severe forms of SDB vs. controls (ODI 5, 20% vs. 0%, p=.047). CONCLUSION: Compared to normotensive controls, preeclamptic subjects experience more SDB events and a greater degree of nocturnal hypoxemia. Further research is needed to determine if SBD, independent of BMI, is a significant contributing factor to the risk of developing preeclampsia. A prospective study of 180 acute myocardial infarction (AMI) patients, investigating whether metabolic perturbations associated with sleep disordered breathing (SDB -based on Watch PAT-100 sleep studies), are present in AMI, and if they affect clinical outcomes. Blood levels of high-sensitivity C-reactive protein (hs-CRP) and markers of oxidative stress (lipid peroxides [PD] and serum paraoxonase-1 [PON-1]), and echocardiography to evaluate cardiac dimensions and pulmonary artery systolic pressure, was performed . RESULTS: SDB was present in 64% of patients. Hs-CRP levels, PD and PON-1 were similar in patients with and without SDB. Echocardiography revealed higher left atrial dimension (P = 0.003) and a significant positive correlation between ODI and pulmonary artery systolic pressure (r = 0.41, P<0.0001).
After median follow up of 68 months, no significant differences were observed between SDB and nonSDB groups with regard to death, heart failure, myocardial infarction and unstable angina. CONCLUSION: Undiagnosed SDB was highly prevalent among patients with AMI. SDB in the setting of AMI is associated with higher pulmonary artery systolic pressure, but not with adverse clinical outcomes.
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To better understand chronic sleep problems among active-duty service members, medical records of 76 active-duty service members who completed enhanced sleep assessments during an 18-month period were retrospectively reviewed. Sleep assessment measures included the Pittsburgh Insomnia Rating Scale, Alcohol Use Disorders Identification Test, Zung Self-Rating Depression Scale, Zung Self-Rating Anxiety Scale, Posttraumatic Stress Disorder Checklist -Military Version, Epworth Sleepiness Scale, Pre-Sleep Arousal Scale, and WatcPAT-200 home sleep studies. RESULTS: Mild to moderate sleep apnea was found in 29% of subjects. Those with higher self-reported posttraumatic stress scores also reported a higher degree of both somatic and cognitive factors interfering with sleep initiation. Those with high posttraumatic stress scores, had a mean 38 minute lower total sleep time and higher apnea/hypopnea, respiratory disturbance, and oxygen saturation indices. CONCLUSION: Enhanced sleep assessments that include traditional self-report tests and a home sleep study can help identify previously undiscovered behavioral and respiratory problems among service members, particularly those with higher posttraumatic stress scores. Investigated whether snoring sounds, recorded using WatchPAT-200 or polysomnography, could be distinguished from breath sounds by 25 subjects exposed to 55 sound sequences, and asked to determine the nature of the sounds and their degree of certainty, and to evaluate whether the sound pressure level in common use and psychoacoustic parameters are suitable for making the distinction. RESULTS: Sixteen percent of the sound sequences could not be classified unequivocally, by raters, although they stated that they were moderately certain about their decision. The sound pressure level and psychoacoustic parameters were capable of distinguishing between breath sounds and snoring sounds at an optimal sensitivity and specificity of 76.9% and 78.8%, respectively. CONCLUSIONS: Although snoring appears to be a subjective impression and a generally valid acoustic definition seems to be impossible, sound pressure level and psychoacoustic parameters are suitable for distinguishing between breath sounds and snoring sounds with moderate validity.
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Impaired endothelial function after aneurysmal
Investigated the relationships of low concentrations of serum magnesium (sMg) and intracellular Mg (iMg) with clinical and vascular parameters, in thiazide-treated hypertensive women who were separated into two groups according to lower (<2.0 mg/dL) or normal (2.0 mg/dL) sMg concentrations, and then according to lower (<3.75 mg/dL erythrocytes) and normal (3.75 mg/dL erythrocytes) iMg concentrations. Carotid ultrasound, radial applanation, and EndoPAT-AI were performed in all patients. RESULTS: Low sMg levels were associated with significantly increased Framingham Risk Score (P=.024), higher systolic and diastolic blood pressures (P<0.05), and carotid intima-media thickness (P=.023). Low concentrations of iMg were related to increased augmentation pressure (P=0.032) and augmentation index (P=0.004).
CONCLUSION:
In diuretic-treated hypertensive women, low sMg was associated with higher blood pressure values, and more intense wave reflection were closely linked to iMg depletion, processes that might contribute to hypertension and other cardiovascular risk factors.
http: //www.ncbi.nlm.nih.gov/pubmed/23735418 Neither Cyclosporine nor Tacrolimus Deteriorate Endothelial Function in Renal Transplant Recipients Assessed With Reactive Hyperernia Index. Grabczewska Z, Oboska K, Adamowicz A, Kasprzak M, Włodarczyk Z, Kubica J. Transplant Proc. 2013 May; 45(4):1567 -1570 Determined EndoPAT-RHI and EndoPAT-AI in 40 renal transplant recipients (RTR), at 48.9 ± 36 months post transplantation, in relation to immunosuppressive drugs tacrolimus (n=22, group 1), or cyclosporine (n=18, group 2), vs. 18 healthy controls. RESULTS: Median RHI in group 1 was 2.00, not different from 1.90 in group 2, or from 2.11 in controls. Multivariate analysis revealed age to be the independent factor influencing RHI in all groups but treatment with calcium channel blockers appeared to be the only independent factor influencing RHI among RTR. AI% values were not significantly different between the 2 RTR groups, but it was significantly higher among controls than among RTR treated with tacrolimus. CONCLUSION: RHI in RTR was not worse than in controls, and was not different between cyclosporine or tacrolimus. Arterial stiffness was dependent on age but not the calcineurin inhibitor, which showed little effect. Hong SJ, Chang HJ, Park S, Kang DR, Shin S, Cho IJ, Shim CY, Hong GR, Ha JW, Chung N. Clin Cardiol. 2013 Aug; 36(8):480-5. Tested whether Atorvastatin could improve endothelial dysfunction (ED) as assessed by EndoPAT-RHI, in 35 first-degree relatives (FDRs) of patients with premature coronary artery disease (CAD) and ED (median age, 52 years, 21 male) in a prospective double-blind trial with a crossover 6 weeks of treatment with atorvastatin 40 mg/day followed by placebo, or vice versa. The primary outcome was the difference of RHI between atorvastatin and placebo treatments. RESULTS: LDL cholesterol was lower after atorvastatin vs. placebo (124 [102-145] mg/dL vs 67 [50-73] mg/dL, P < 0.001), but neither RHI, nor the augmentation index were different after atorvastatin vs. placebo, both in subjects with or without indications for statin treatment. CONCLUSION: Despite improvement in the lipid profile, atorvastatin failed to improve ED in the FDRs of patients with premature CAD with ED.
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